TOP TIERMARKET NEWSWIRE
News & sentiment

APOGEE THERAPEUTICS (APGE) — News & AI sentiment

APOGEE THERAPEUTICS (APGE) news roundup. 1 story in the past week, 8 over 30 days. Average 30-day sentiment is 61/100. Recent insider activity (SEC Form 4, 90-day window): 0 purchases totalling $0 and 5 sales totalling $18.2M — net selling of $18.2M. No congressional trade disclosures in the last 90 days. Data shown on this page is delayed 4 hours. Real-time access — including the live wire, real-time alerts, the live S&P 500 heatmap, and the AI Top Trades long/short board — is available with a Top Tier Newswire Pro subscription.

Public view, delayed 4h. For real-time news, alerts, AI sentiment and the long/short AI Top Trades board:Open in the live terminal →
24h stories
0
7d stories
1
avg sentiment 73/100
30d stories
8
avg sentiment 61/100
Insider net (90d)
$18.2M
0 buys · 5 sells
Congress (90d)
0
0 buys · 0 sells

APGE news in the last 24 hours, 7 days, 30 days and 90 days

How much APGE coverage the wire captured in each window, with the average AI sentiment across those stories. Counts are of stories that have cleared the 4-hour public delay.

Time windowAPGE storiesAvg AI sentimentRead
Last 24 hours0—no coverage
Last 7 days173/100APGE headlines →
Last 30 days861/100APGE headlines →
Last 90 days7761.6/100APGE headlines →

Latest stories on APGE

4d ago
Sep 3
Sep 3
Sep 3
Sep 3
Sep 3
Sep 3
Aug 17
BTIG downgrades Apogee Therapeutics stock rating after AbbVie deal
Investing.com Analyst Ratings34 · bearishanalyst
Aug 12
Aug 11
Aug 11
Aug 10
Apogee Therapeutics reports Q2 results
Seeking Alpha67 · bullishm&a
Aug 10
Aug 10
Aug 5
Aug 4
Jul 31
Jul 31
Jul 31
Jul 31
Jul 31
Jul 31
Jul 23
Jul 20
Jul 14
Open APGE in the live Top Tier Newswire terminal for real-time stories, sentiment, insider + congress alerts, and the AI Top Trades long/short board.Start a 1-day free trial →